Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Genentech granted FDA orphan status for gastric cancer treatment
Genentech granted FDA orphan status for gastric cancer treatment
Genentech granted FDA orphan status for gastric cancer treatment
Submitted by
admin
on May 2, 2014 - 9:53am
Source:
Yahoo/Fly on the Wall
News Tags:
Genentech
FDA
gastric cancer
cancer of the gastro-esophageal junction
orphan drugs
Ipatasertib
Headline:
Genentech granted FDA orphan status for gastric cancer treatment
Do Not Allow Advertisers to Use My Personal information
